VIDEOS

GRACE is excited to bring to you more in our new series on surviving with cancer GRACE is excited to bring to you more in our series on surviving with...

GRACE is excited to bring to you more in our new series on surviving with cancer GRACE is excited to bring to you more in our series on surviving with...

GRACE is excited to bring to you more in our new series on surviving with cancer GRACE is excited to bring to you more in our series on surviving with...

Drs Zofia Piotrowska, H. Jack West, and Taofeek Owonikoko sit down to discuss a series of case-based scenarios. In this video, the doctors discuss the optimal 1st line treatment for a patient with advanced non squamous non small cell lung cancer, high PD-L1, and no driver mutation.

Drs Zofia Piotrowska, H. Jack West, and Taofeek Owonikoko sit down to discuss a series of case-based scenarios. In this video, the doctors discuss if there is a best systemic therapy option for a patient with advanced non-squamous NSCLC, low PD-L1 and no driver mutation.

ARTICLES

Únete a nosotros, sábado 12 de agosto a las 9:00 a.m. En este foro anual de pacientes en vivo, los principales oncólogos torácicos de todo el mundo...

Thank you for joining us on Saturday for the 2023 Targeted Therapies in Lung Cancer Patient Forum! The full unedited versions of the 2023 Targeted...

Thank you for joining us on Saturday for the 2023 Targeted Therapies in Lung Cancer Patient Forum! The full unedited versions of the 2023 Targeted...

Thank you for joining us on Saturday for the 2023 Targeted Therapies in Lung Cancer Patient Forum! The full unedited versions of the 2023 Targeted...

Thank you for joining us on Saturday for the 2023 Targeted Therapies in Lung Cancer Patient Forum! The full unedited versions of the 2023 Targeted...

ONLINE COMMUNITY

Hello, I want to share this video, Cancer Growth Rate and Managing Slow-Growing Lung Cancers. A lot has changed in treatment and management in the...

My healthcare provider has been monitoring some nodules since 2016--GGO, and now a sub-solid nodule that has increased 6 mm in 2 years from 1.6 cm to...

Register for free and join us on this live, virtual and interactive patient education event! This event includes presentations and panel discussions...

Register for free and join us on this live, virtual and interactive patient education event! This event includes presentations and panel discussions...

Recent Comments

updates:
My father received…
Comment By JanineT GRACE … on Jan 29, 2025 10:22 am
updates:
My father received…
Comment By JanineT GRACE … on Jan 29, 2025 10:22 am
Thank you so much for the…
Comment By SavannahRae on Jan 14, 2025 1:52 pm
Check out Small Cell…
Comment By JanineT GRACE … on Jan 7, 2025 10:10 am

How to Vet a Treatment Idea

Article

From the GRACE Archives - Originally Published November 21, 2009 | By Dr. Weiss

I’ve been impressed by many things about GRACE and its members. Among these many things are the thirst for new information and better treatments. I also admire the openness of the members both to new ideas, and to questioning these ideas.

What Makes a Triple Negative Breast Cancer Negative - Reis Filho

Video
GRACE and PRIME Oncology have partnered to present to you information from the prIME Oncology satellite symposium held in conjunction with the 2018 San Antonio Breast Cancer Symposium (SABCS).

In the following series of videos, faculty discuss therapeutic options for triple-negative breast cancer. Topics discussed include the biology of triple-negative breast cancer, current treatment options, novel targeted treatments, PARP inhibitors, and immunotherapy.  

Current Standard of Care in Triple Negative Breast Cancer - Yardley

Video
GRACE and PRIME Oncology have partnered to present to you information from the prIME Oncology satellite symposium held in conjunction with the 2018 San Antonio Breast Cancer Symposium (SABCS).

In the following series of videos, faculty discuss therapeutic options for triple-negative breast cancer. Topics discussed include the biology of triple-negative breast cancer, current treatment options, novel targeted treatments, PARP inhibitors, and immunotherapy.  

Subscribe to Just Diagnosed